Sophie is the technical lead for the International Screening Standards initiative , which seeks to support the harmonization and standardization of screening approaches around the world. She is a member of the International Gene Synthesis Consortium (IGSC), the OECD Synthetic Biology Working Party, Pandemic Action Network (PAN), several other international policy fora and the former French representative at ISO TC 276: Biotechnology working group.

Previously, Sophie played a critical role in the revision of the ASPR/HHS Screening Framework Guidance for providers and users of synthetic nucleic acides, namely by providing expert input on the specific challenges faced by benchtop device manufacturers, and the solutions developed by them. At the EU level, Sophie actively contributes to discussions around the EU Biotech Act and the Bioeconomy, working collaboratively with key stakeholders across the synthetic biology ecosystem. She regularly speaks at international conferences including SynBioBeta, SynbiCITE, and the OECD.

She has spent much of her career working at the interface of science, public policy, and health, building trusted relationships with governments, civil society, and the private sector. Prior to joining IBBIS, she held senior roles in international organizations, think tanks, and the private sector. She lectures on governance and emerging technologies at Sciences Po (Paris). Sophie holds post-graduate degrees from the Sorbonne Law School, Johns Hopkins School of Advanced International Studies (SAIS), and the London School of Hygiene and Tropical Medicine (LSHTM).